Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes.

Melissa R Riester Andrew R ZulloRicha JoshiLori A DaielloKaleen N HayesDarae KoDae Hyun KimSebastian SchneeweissSarah D Berry

Published in: Diabetes, obesity & metabolism (2024)

SGLT2is do not have superior, and may have inferior, effectiveness compared with GLP-1RAs for cardiovascular and mortality outcomes in NH residents. Residents initiating SGLT2is should be monitored closely for DKA.

Keyphrases

randomized controlled trial
systematic review
cardiovascular events
risk factors
room temperature
type diabetes
adipose tissue
coronary artery disease
wild type
perovskite solar cells